A recall has been issued for nasal solution products used in hospitals because of the potential for errors in administering the drug. Endo Inc. announced on Dec. 20 that one of its operating ...
Epinephrine nasal solutions from BPI Labs and Endo USA should not be used, according to the FDA. Similarities between the packaging for certain intranasal and intravenous epinephrine products may ...
The company is voluntarily recalling all lots of Adrenalin Chloride Solution (EPINEPHrine nasal solution, USP) 30 mg/30 mL (1 mg/mL) 30 mL vials due to misleading labeling and its status as an ...
PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--TD Solutions announced today that they have initiated development of Epi Mist™ HypoSpray Epinephrine for allergic reactions. More than 35 million Americans ...
Presented at Respiratory Drug Delivery 2024, the Nasdepi Canine Study Indicates the Dry Powder Nasal Solution Provides a Faster and More Effective Treatment for Anaphylaxis as a Result of Severe ...
Endo, Inc (OTCQX: NDOI) (“Endo”), announced today that one of its operating subsidiaries, Endo USA, Inc., is voluntarily recalling all lots within expiry of Adrenalin® Chloride Solution (EPINEPHrine ...
Aquestive Therapeutics' Anaphylm offers a unique, non-injectable epinephrine solution for anaphylaxis, with NDA decision expected imminently. Anaphylm's advantages—wallet portability, rapid onset, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results